{"id":"W4393965986","doi":"10.1016/s0140-6736(24)00317-9","title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":349,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Meso Scale Diagnostics","keywords":"Pembrolizumab; Medicine; Placebo; Cervical cancer; Chemoradiotherapy; Clinical trial; Internal medicine; Oncology; Double blind; Cancer; Immunotherapy; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001629338,0.00104071,0.003485812,0.0002141529,0.0003937286,0.0002956402,0.0008873674,0.0005402856,0.00275138],"category_scores_gemma":[0.0008115465,0.0005217736,0.0008974316,0.001292396,0.0004064247,0.0002775404,0.0001046953,0.001308702,0.0001188439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006654403,"about_ca_system_score_gemma":0.001844374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009022873,"about_ca_topic_score_gemma":0.001408555,"domain_scores_codex":[0.9937322,0.0005211658,0.001597088,0.001543576,0.00114509,0.001460895],"domain_scores_gemma":[0.9913926,0.005724456,0.0005007797,0.001401314,0.0002486705,0.000732144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8785403,0.001500055,0.0001747221,0.0004755387,0.002436136,0.0004029192,0.0002923762,0.00009503981,0.0001034304,0.0001014698,0.04624061,0.0696374],"study_design_scores_gemma":[0.8653309,0.01551757,0.00005096248,0.0005662938,0.00233361,0.00009743355,0.00009287584,0.0009786425,0.001023696,0.0001218876,0.1131766,0.0007095222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.930389,0.01017567,0.007904032,0.02092711,0.003838561,0.02282909,0.001968801,0.0009802276,0.0009875251],"genre_scores_gemma":[0.9267035,0.01542249,0.003281558,0.006866846,0.01765186,0.01595293,0.0007661862,0.0005486913,0.01280589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06892788,"threshold_uncertainty_score":0.9997234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0738478402354054,"score_gpt":0.4051979508818233,"score_spread":0.3313501106464179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}